We love

CV Lab is the first incubator fully focused on cardiovascular innovation in Europe: it selects the most promising ideas and turns them into spin-offs that can be funded by international venture capital

CV Lab is an incubator focused on cardiovascular projects. We take the most promising ideas through patenting, prototyping and proof-of-concept, until we are ready to spin-off a new company and seek venture capital funding.

We make the most of a network of entrepreneurs and experts with strong expertise in the biomedical sector. We work with the best industry specialists. We are a lean structure very close to researchers and to clinical needs. We are at ease in situations where enterprise risk is higher.

We are open to all ideas, but we prefer early projects. We choose the most promising in terms of market potential, clinical need, innovative content and scientific evidence. We prioritize the most structured proposals, aiming to achieve proof-of-concept within 18-24 months and to become standard-of-care within 4 to 8 years.


Contact us




We protect every invention with the most rigorous patenting strategy. If a patent application has already been submitted or a patent has already been granted, we help strengthen the intellectual property protection, as necessary

bench tests

We perform the most appropriate combination of bench/in vitro tests and in silico tests, involving the best partners in each area. These tests help us to develop prototype and patent


Once the feasibility tests are performed, we take the idea from the inventor’s mind to the prototyper’s bench, aiming to move closer to the large-scale, industrial product that the prototype will become

preclinical tests

In-vivo tests on the prototypes, carried out in compliance with the law and in the laboratories of excellence, allow us to collect preclinical data, which often represent a necessary step to apply for product registration in the future

team building

As the idea approaches proof-of-concept, the incubator team selects the CEO, the CTO and any additional member of the team that will lead the newly-created spin-off and continue the development of the product towards the market

regulatory path

During the incubation process, Cardiovascular Lab develops a regulatory plan to achieve product registration and commercial access to major international markets as efficiently and quickly as possible

Who we are

A unique experience in medtech

Meet the CV Lab Team

How does it work?

Cardiovascular Lab partners with clinicians, scientists and engineers to evaluate the market potential for their ideas and patents, and to accompany them in their entrepreneurial journey


    We evaluate hundreds of ideas and projects per year, selecting the most promising and mature


    The incubation team validates the feasibility of the proposed technology and takes it to proof-of-concept


    Once the idea is validated, the project becomes a real company and continues its path towards the market


    The new company is supported in its search for international investment

Our best startups

Companies born thanks to CV Lab support

Dyverto AG operates in the endovascular space, developing new approaches to the treatment of aneurysmal disease.

Fidelio Medical operates in the diagnostics space, developing a point-of-care technology and a digital health platform for iron deficiency anemia.

Kapto Medical operates in the mechanical thrombectomy space, developing new solutions for neurovascular and peripheral application.

reCross develops a septal closure device based on unique, patented membrane technology. This disruptive technology effectively differentiates reCross from commercially available septal occluders.

Contact us

Please reach us to get information on the incubation process or to submit your idea

Cardiovascular Lab

Via Locatelli, 2
20124 Milano